≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Other drug-induced secondary parkinsonism

PheWeb

OTHER_DRUGADVERS_SECONDA_PARKINSONI

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 G21.1#

219

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10

219

diagram downward connector

Check minimum number of events None

219

diagram downward connector

Include endpoints None

219

diagram downward connector
OTHER_DRUGADVERS_SECONDA_PARKINSONI

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF5

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 219 107 112
Unadjusted prevalence (%) 0.06 0.05 0.07
Mean age at first event (years) 59.53 61.29 57.85

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: OTHER_DRUGADVERS_SECONDA_PARKINSONI – Other drug-induced secondary parkinsonism
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Other drug-induced secondary parkinsonism
after Other drug-induced secondary parkinsonism

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Other drug-induced secondary parkinsonism

↥